Letter: risk of hepatocellular carcinoma in immune-tolerant phase of chronic hepatitis B-authors' reply

Aliment Pharmacol Ther. 2020 Sep;52(5):913-914. doi: 10.1111/apt.15992.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Carcinoma, Hepatocellular* / epidemiology
  • Carcinoma, Hepatocellular* / etiology
  • Hepatitis B e Antigens
  • Hepatitis B virus
  • Hepatitis B, Chronic* / complications
  • Hepatitis B, Chronic* / epidemiology
  • Humans
  • Liver Neoplasms* / epidemiology
  • Liver Neoplasms* / etiology

Substances

  • Hepatitis B e Antigens